OptraSCAN Awarded by ETNOW for Best Innovation in Digital Pathology
Mumbai, India – OptraSCAN® digital pathology solutions provider has been awarded with best innovation in digital pathology by the Economic Times (ET Now) and World Health & Wellness Congress & Awards at their recent event in Mumbai, on 14th February. Addressed as the highest honor by the ET NOW and presented by the World Health & Wellness Congress & Awards – a leading international awards organization honoring excellence in the medical and healthcare domain. The nomination and selection for the award was done by a panel comprised of global healthcare leaders and experts.
OptraSCAN has set the benchmark for innovation and is disrupting the digital pathology marketplace through its mission of- affordable healthcare. With over four patents to its credit, OptraSCAN is empowering the pathologist community by providing easy to adopt digital pathology solutions at economical costs.
“After my first venture BioImagene, which was acquired by Roche Diagnostics, I had no plans to enter Digital Pathology market, till 2015, when Government of India posed a challenge to me for making Digital Pathology affordable for the emerging world.”, said Abhi Gholap, Founder & CEO, OptraSCAN®.
He further added, “OptraSCAN disrupted the high costs Digital Pathology market through its affordable high-quality systems, thanks to Nikon Optics. Soon our competitors will have no alternative than to make their systems affordable too, else they will lose their market share to us, the way it’s happening in India and China. I’m thankful to Times Group, a $5 bn entity for this award”.
OptraSCAN scanners effectively scan and acquire whole slide images for viewing, storing, reporting and real-time sharing of information across hospitals, labs and their networks as compared to the use of optical microscopes. All the scanners are cloud-enabled and well equipped with brightfield, fluorescence, frozen section and confocal imaging modalities. These benchtop, low and high throughput scanners are lightweight and can easily fit into small workspaces. They provide flexibility for storing, archiving and managing digital images and its metadata. OptraScan’s AI & ML- based image analysis solutions have been developed on an automated algorithm system that gives an accurate, rapid and reproducible analysis of nuclear and membrane biomarkers as well as of immuno-oncology, prostate cancer and cytology imaging.
In India, OptraSCAN is the only company that has completed a mass validation, of over 10,000 patient cases and has received a positive response from leading cancer research centers, recognized hospitals, diagnostics laboratories, academic and research institutes.
About OptraSCAN, Inc.
OptraSCAN® are pioneers in the On-Demand Digital Pathology® System, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the barriers to “Go Digital” no matter the size of the pathology lab, the lab’s throughput or global location.
OptraSCAN’s end-to-end digital pathology solution provides effective acquisition of whole slide images, viewing, storing, real time sharing, reporting and AI & ML based Image analysis solutions via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter.
Media Inquiries Contact:
Anjana Athanikar| Manager – Marketing Communications | 91.20.66540900 x 231 | a.athanikar@optraventures.com
Source: OptraSCAN
